Most of these conserved TFBSs involved in breast cancer (e.g., AP-1, NFκB, and STAT5), stem cells and embryonic development (e.g., OCT1, PAX6, GATA1), and therefore had the highest potential for regulating CD44 and for being involved in breast cancer. This evidence concerns the gene FOS and breast carcinoma.